Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (1150)	4/15/1998 8:36:00 AM
From: Cosmo Daisey	Read Replies (2) \| Respond to of 9523

Jim, """Placebo 24.8%""" This Placebo effect is in line with just about all the ED studies that have been done. I guess the 84.3% is what ED patients are looking for and if you read the comments from ED posters now using Viagra here and on other boards they probably don't care if the results are Placebo or Viagra as long as they get results. I am hearing reports of patients being back in business after a ten year pause. Results are what counts. cdaiseyPhD@placebo-studies.com

To: James Baker who wrote (1150)	4/15/1998 8:43:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

Jim <<Just have to say that any study with 24.8% placebo response rate was not dealing with significant ED patients!When you net out the placebo % your are left with 50% true benefit from the drug Viagra at the highest recommended dose! NOT what the public has been lead to expect, is it?>> Jim: I disagree totally. Most physicians realize that ED has a very high placebo effect of between 20-30%. Moreover, there are not many drugs that have an overall efficacy rate of 77%-84% particularly for a therapeutic area where the oral efficacy rates was 30-40%. As one patient reported " If Viagra just gave me the placebo effect I 'll take it." One final point: at the 1998 AUA meeting, there will be two papers that will document "Disappointing Results" with non-oral ED therapies (see abstracts #903 and #905). The results of these two unfunded studies should strongly support the use of oral ED agents. Have PFun! BigKNY3